ETFs Canopy Growth Corporation

WEED

CA1380357048

Pharmaceuticals

Market Closed - Toronto S.E. Other stock markets 21:00:00 13/09/2024 BST			5-day change	1st Jan Change
6.510 ^CAD	+1.24%		+7.25%	-3.70%

08-27	Health Care Flat as Cannabis Shares Slide -- Health Care Roundup	DJ
08-27	Pot stocks fall as US DEA pushes cannabis reclassification hearing to December	RE

ETFs positioned on Canopy Growth Corporation

Name	Weight	AuM	1st Jan change	Investor Rating
AMPLIFY ETF TR SEYMOUR CANNABIS - USD	3.96%	28 M€	+1.41%	-
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY	0.05%	18 M€	+9.57%	-
CSIF (IE) MSCI WORLD ESG LEADERS BLUE UCITS ETF - BH - EUR	0.01%	270 M€	-.--%	-
CSIF (IE) MSCI WORLD ESG LEADERS BLUE UCITS ETF - B - USD	0.01%	458 M€	-.--%
CSIF (IE) MSCI WORLD ESG LEADERS BLUE UCITS ETF - BH - CHF	0.01%	209 M€	+14.54%	-

Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. Its Rest-of-world cannabis segment includes the production, distribution, and sale of a diverse range of cannabis and hemp products internationally. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers.

Employees

1,029

Sector

Pharmaceuticals

Calendar

24/09/2024 - Annual General Meeting

More about the company